GLPwatch
Papers (10389)
Page 158 of 174, ranked by citation count.
- [Oral semaglutide, first oral GLP-1 receptor agonist (Rybelsus®)].
- [Effects of liraglutide combined with vitamin D on non-alcoholic fatty liver induced by high fat in mice and its mechanism].
- SGLT2 inhibitors and incretin-based therapies for metabolic dysfunction-associated steatohepatitis: a systematic review.
- Summaries for patients: Does adding exenatide to insulin treatment benefit patients with type 2 diabetes?
- Tirzepatide in Metabolic Diseases: Clinical Efficacy and Safety Beyond Diabetes and Obesity.
- Risk of Age-Related Ocular Diseases in Non-Diabetic Adults With Obesity Using Glucagon-Like Peptide 1 Receptor Agonists.
- Semaglutide: An emerging treatment option for patients with obesity related HFpEF.
- Addressing patient concerns about the 'newness' and long-term safety of GLP-1 receptor agonists: A clinician's guide to counseling.
- Diabetic ketoacidosis induced by liraglutide overdose for weight loss in a type 2 diabetes patient: A case report.
- Retraction Note: Lixisenatide protects doxorubicin-induced renal fibrosis by activating wNF-κB/TNF-α and TGF-β/Smad pathways.
- Response to the letter from Horowitz et al. to the Editor relating to the publication 'Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes' by Dahl et al.
- [The renal protective effect and mechanism of liraglutide in diabetic mice induced by high-fat diet].
- GLP-1 receptor agonists and their role in managing type 2 diabetes.
- Major Adverse Cardiovascular Event Outcomes in Patients With Obesity and Type 2 Diabetes Undergoing Medical Weight Management.
- [The extra-glycemic effects of liraglutide: focus on cardiometabolic markers].
- Cardio-kidney-metabolic protective effects of semaglutide across the spectrum of chronic kidney disease.
- Development of a Long-Acting and Stapled Dual Amylin and Calcitonin Receptor Agonist as Monotherapy and Combination with GLP-1R Agonists for the Treatment of Obesity.
- [Effects of glucagon-like peptide-1 on appetite and body weight: preclinical and clinical data].
- "Ozempic Limb": Understanding the Impact of Semaglutide on Prosthesis Use and Residual Limb Care in Individuals With Lower Limb Amputation.
- The efficacyand safety of once weekly injectable semaglutide (Ozempic) among patients with Type 2 diabete sintertiary care hospital: A Retrospective Study.
- Potential Role of Imaging in the Evaluation of Adiposity and Approval of Anti-Obesity Drugs.
- Obesity medications and precision nutrition: synergistic interventions and integrated approach in obesity management.
- A review of survodutide: a new dual acting agonist.
- Cost-Effectiveness of Highly Effective Glucose-Lowering Agents: Do Current Practices Optimize Clinical and Economic Outcomes?
- Psychosocial Outcomes in Telemedicine and Long-Acting Incretin-Specific Behavioral Intervention.
- Dulaglutide Effect on Proteins Associated With CKD Progression.
- Tirzepatide retention in iWAT with mesoporous polydopamine encapsulation enhances weight loss through leptin receptor signaling.
- Non-invasive tests for fibrotic MASH: Decision aids in MASH therapeutics and predictors of liver-related events.
- Implementation of the IWQOL-Lite-CT in Observational Research: Comparison of Baseline Scores With a Clinical Trial Population and Psychometric Evaluation.
- Tirzepatide versus dulaglutide in heart failure: another SURPASS attempt yielding a tie.
- Prediction of the optimal dose of exenatide in patients with type 2 diabetes mellitus with renal impairment using physiologically based pharmacokinetic modeling.
- Tirzepatide and semaglutide: different twins?
- Cost-effectiveness analysis of oral semaglutide versus subcutaneous dulaglutide in patients with type 2 diabetes mellitus: A Markov model study.
- Liraglutide reduces the apoptosis of feeding and appetite-suppressing neurons in the hypothalamus of obese rats association with the PI3K/AKT/Foxo1 pathway.
- Unexpected Residual Gastric Contents in a Patient After Holding Semaglutide After Standard Fasting Guidelines: A Case Report.
- Response by Wiberg et al to Letter Regarding Article, "Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac Arrest: A Randomized Controlled Trial".
- Methyl Proton Spin Relaxation (<i>R</i><sub>2</sub>/<i>R</i><sub>1</sub>) Enables Sensitive Detection of pH-Dependent Oligomerization in GLP-1 Analogs.
- What are the cardiovascular effects of the newer classes of drugs for type 2 diabetes?
- Pattern of semaglutide prescription in a real-world Canadian patient cohort.
- Estimation of Interventional Effects in Clinical Trials With a Repeatedly Measured Mediator.
- Risk stratification using coronary artery calcium and potential benefit of semaglutide therapy: A cost-effectiveness modelling study.
- [Exenatide promotes cholesterol efflux in pancreatic tissue of obese diabetic rats].
- Weight-Lowering Drugs and Natural Female Fertility-A Systematic Review and Meta-Analysis.
- Management of Obese Patients with Cardiovascular Disease with Emerging Weight-Lowering Drugs: A Narrative Review.
- Small Intestine-Permeable Cyclic Peptide-Mediated Enhancement of Fc-Fusion Protein Absorption in Mice.
- Semaglutide in obesity and type 2 diabetes: A review of clinical trial evidence from 1 to 5 semaglutide treatment effect in people with obesity program.
- Significant elevation of serum CA19-9 and CA242 levels induced by dulaglutide.
- The Impact of GLP-1-Based Therapies on Cardiovascular Outcomes in Type 2 Diabetes: A Comprehensive Systematic Review and Network Meta-Analysis.
- A RESPONSE TO: "COST-EFFECTIVENESS OF ORAL SEMAGLUTIDE ADDED TO CURRENT ANTIHYPERGLYCEMIC TREATMENT FOR TYPE 2 DIABETES".
- Tirzepatide Beyond Diabetes and Obesity: Systematic Review and Meta-Analysis of Multisystem Therapeutic Benefits.
- Pharmacotherapy for Children and Adolescents With Overweight or Obesity: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
- Semaglutide treatment reverses HFD induced hippocampal microglia activation and improves cognitive dysfunction.
- Quality and reliability of semaglutide content on different Chinese short video platforms: a study focusing on side effects.
- Use of semaglutide and tirzepatide among people with multiple sclerosis.
- The effect of exenatide on fasting bile acids in newly diagnosed type 2 diabetes mellitus patients, a pilot study.
- Liraglutide therapy in an adolescent with Prader‑Willi syndrome and concomitant diabetes mellitus.
- Effect of liraglutide on depressive symptoms in overweight or obese patients with type 2 diabetes: protocol for a pilot randomized controlled trial.
- Discovery and identification of semaphorin 4D as a bioindicator of high fracture incidence in type 2 diabetic mice with glucose control.
- Retrospective comparison of the clinical effects of oral semaglutide and SGLT2 inhibitors treatment in patients with type 2 diabetes.
- Effectiveness for adding or switching from other incretin-related drugs to oral semaglutide in type 2 diabetes.